Analyst Consensus
- Current Price
- 60.88 $
- Target (Low)
- 69.00 $
- Target (Mean)
- 80.44 $
- Target (High)
- 100.00 $
- Recommendation
- Strong Buy
- Number of Analysts
- 16
Recommendation Distribution
Recommendation Distribution| Strong Buy | 5 |
|---|
| Buy | 13 |
|---|
| Hold | 0 |
|---|
| Sell | 0 |
|---|
| Strong Sell | 0 |
|---|
Key Ratios
- Net Profit Margin
- -20.5%
- Operating Margin
- -7.9%
- Gross Margin
- 37.2%
- Return on Equity (ROE)
- -4.2%
- Return on Assets (ROA)
- -2.1%
- Revenue Growth
- 118.6%
- Debt/Equity
- 44.02
- Current Ratio
- 7.18
- Beta
- 1.84
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| Jun 5, 2026 | DA Davidson | Buy → Buy |
| Jun 1, 2026 | Needham | Buy |
| May 22, 2026 | Barclays | Overweight |
| May 20, 2026 | DA Davidson | Buy → Buy |
| May 11, 2026 | Morgan Stanley | Overweight → Overweight |
| May 8, 2026 | Wedbush | Outperform → Outperform |